NEXUS AG (NXU.DE) Stock Fundamental Analysis
FRA:NXU - DE0005220909 - Common Stock
70.7 EUR
-0.6 (-0.84%)
Taking everything into account, NXU scores 6 out of 10 in our fundamental rating. NXU was compared to 11 industry peers in the Health Care Technology industry. NXU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NXU is valued quite expensively, but it does show have an excellent growth rating. These ratings would make NXU suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year NXU was profitable.
In the past year NXU had a positive cash flow from operations.
NXU had positive earnings in each of the past 5 years.
In the past 5 years NXU always reported a positive cash flow from operatings.
1.2 Ratios
NXU has a Return On Assets (6.82%) which is comparable to the rest of the industry.
NXU has a Return On Equity (11.31%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 8.78%, NXU is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
NXU had an Average Return On Invested Capital over the past 3 years of 7.85%. This is in line with the industry average of 9.32%.
The 3 year average ROIC (7.85%) for NXU is below the current ROIC(8.78%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROIC | 8.78% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
1.3 Margins
With a decent Profit Margin value of 12.10%, NXU is doing good in the industry, outperforming 72.73% of the companies in the same industry.
NXU's Profit Margin has improved in the last couple of years.
The Operating Margin of NXU (15.58%) is better than 81.82% of its industry peers.
In the last couple of years the Operating Margin of NXU has grown nicely.
Looking at the Gross Margin, with a value of 85.51%, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Gross Margin of NXU has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% |
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NXU is still creating some value.
The number of shares outstanding for NXU remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NXU has more shares outstanding
The debt/assets ratio for NXU has been reduced compared to a year ago.
2.2 Solvency
NXU has an Altman-Z score of 5.52. This indicates that NXU is financially healthy and has little risk of bankruptcy at the moment.
NXU has a Altman-Z score of 5.52. This is amongst the best in the industry. NXU outperforms 100.00% of its industry peers.
NXU has a debt to FCF ratio of 0.41. This is a very positive value and a sign of high solvency as it would only need 0.41 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.41, NXU belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
NXU has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NXU (0.05) is better than 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Altman-Z | 5.52 |
ROIC/WACC1.22
WACC7.22%
2.3 Liquidity
A Current Ratio of 1.93 indicates that NXU should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.93, NXU is doing good in the industry, outperforming 72.73% of the companies in the same industry.
NXU has a Quick Ratio of 1.89. This is a normal value and indicates that NXU is financially healthy and should not expect problems in meeting its short term obligations.
NXU's Quick ratio of 1.89 is amongst the best of the industry. NXU outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 |
3. Growth
3.1 Past
NXU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.35%, which is quite impressive.
NXU shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.97% yearly.
Looking at the last year, NXU shows a small growth in Revenue. The Revenue has grown by 7.65% in the last year.
NXU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.11% yearly.
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
3.2 Future
The Earnings Per Share is expected to grow by 15.50% on average over the next years. This is quite good.
NXU is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.47% yearly.
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 37.61, the valuation of NXU can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of NXU is on the same level as its industry peers.
NXU is valuated rather expensively when we compare the Price/Earnings ratio to 27.07, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 32.01, which means the current valuation is very expensive for NXU.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NXU is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.59. NXU is valued slightly more expensive when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.61 | ||
| Fwd PE | 32.01 |
4.2 Price Multiples
NXU's Enterprise Value to EBITDA is on the same level as the industry average.
NXU's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.51 | ||
| EV/EBITDA | 16.1 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of NXU may justify a higher PE ratio.
NXU's earnings are expected to grow with 15.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.58
PEG (5Y)1.79
EPS Next 2Y14.95%
EPS Next 3Y15.5%
5. Dividend
5.1 Amount
NXU has a yearly dividend return of 0.32%, which is pretty low.
Compared to an average industry Dividend Yield of 3.59, NXU has a dividend in line with its industry peers.
With a Dividend Yield of 0.32, NXU pays less dividend than the S&P500 average, which is at 2.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
5.2 History
The dividend of NXU has a limited annual growth rate of 2.17%.
Dividend Growth(5Y)2.17%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
11.69% of the earnings are spent on dividend by NXU. This is a low number and sustainable payout ratio.
The dividend of NXU is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.69%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
FRA:NXU (9/9/2025, 7:00:00 PM)
70.7
-0.6 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners55.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.22B
Analysts45.71
Price Target71.4 (0.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.32% |
Yearly Dividend0.22
Dividend Growth(5Y)2.17%
DP11.69%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.9%
PT rev (3m)0.9%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 37.61 | ||
| Fwd PE | 32.01 | ||
| P/S | 4.55 | ||
| P/FCF | 24.51 | ||
| P/OCF | 20.28 | ||
| P/B | 4.25 | ||
| P/tB | 15.31 | ||
| EV/EBITDA | 16.1 |
EPS(TTM)1.88
EY2.66%
EPS(NY)2.21
Fwd EY3.12%
FCF(TTM)2.88
FCFY4.08%
OCF(TTM)3.49
OCFY4.93%
SpS15.55
BVpS16.63
TBVpS4.62
PEG (NY)2.58
PEG (5Y)1.79
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.82% | ||
| ROE | 11.31% | ||
| ROCE | 11.71% | ||
| ROIC | 8.78% | ||
| ROICexc | 15.25% | ||
| ROICexgc | N/A | ||
| OM | 15.58% | ||
| PM (TTM) | 12.1% | ||
| GM | 85.51% | ||
| FCFM | 18.55% |
ROA(3y)6.17%
ROA(5y)6.42%
ROE(3y)9.56%
ROE(5y)10.69%
ROIC(3y)7.85%
ROIC(5y)8.2%
ROICexc(3y)12.19%
ROICexc(5y)11.45%
ROICexgc(3y)147.03%
ROICexgc(5y)150.84%
ROCE(3y)10.47%
ROCE(5y)10.94%
ROICexcg growth 3Y-0.23%
ROICexcg growth 5Y4.33%
ROICexc growth 3Y3.77%
ROICexc growth 5Y2.6%
OM growth 3Y4.31%
OM growth 5Y3.41%
PM growth 3Y8.94%
PM growth 5Y9.93%
GM growth 3Y0.31%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.41 | ||
| Debt/EBITDA | 0.25 | ||
| Cap/Depr | 54.49% | ||
| Cap/Sales | 3.87% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.85% | ||
| Profit Quality | 153.36% | ||
| Current Ratio | 1.93 | ||
| Quick Ratio | 1.89 | ||
| Altman-Z | 5.52 |
F-Score8
WACC7.22%
ROIC/WACC1.22
Cap/Depr(3y)46.55%
Cap/Depr(5y)41.01%
Cap/Sales(3y)3.52%
Cap/Sales(5y)3.36%
Profit Quality(3y)122.34%
Profit Quality(5y)137.83%
High Growth Momentum
Growth
EPS 1Y (TTM)30.35%
EPS 3Y17.9%
EPS 5Y20.97%
EPS Q2Q%25.55%
EPS Next Y14.6%
EPS Next 2Y14.95%
EPS Next 3Y15.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.65%
Revenue growth 3Y11.59%
Revenue growth 5Y12.11%
Sales Q2Q%11.17%
Revenue Next Year9.04%
Revenue Next 2Y10.1%
Revenue Next 3Y10.39%
Revenue Next 5Y10.47%
EBIT growth 1Y27.31%
EBIT growth 3Y16.4%
EBIT growth 5Y15.93%
EBIT Next Year66.24%
EBIT Next 3Y29.63%
EBIT Next 5YN/A
FCF growth 1Y122.1%
FCF growth 3Y16.82%
FCF growth 5Y17.03%
OCF growth 1Y112.34%
OCF growth 3Y17.98%
OCF growth 5Y15.93%